Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
Background. Posttransplant lymphoproliferative disorders (PTLDs) occur after solid organ transplantation. Treatment guidelines include reduction in immunosuppression (RIS), radiation, rituximab, chemotherapy, and immunological agents. We present a rare case of recurrent diffuse large B-cell lymphoma...
Saved in:
| Main Authors: | Bharat Malhotra, Ahmad K. Rahal, Hussam Farhoud, Dennis F. Moore, K. James Kallail |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2015/801082 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01) -
Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01) -
Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01) -
Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01) -
Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Clare J. Twist, et al.
Published: (2013-01-01)